Human Papillomavirus (HPV) Testing Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251388 | Category: Medical Care | Pages: 117 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

HPV infectionscaninfect thegenitalareasof menincludingtheskinonandaroundthepenisoranus. Theseinfectionscanalso bespreadto themoutHandthethroat. EvenwhenHPV infectionsarepersistent to themalepopulationandcancauseseverediseasessucHasgenitalwarts, analcancers, penilecancers, andcancersof theoropharynx, thereiscurrentlyno HPV test recommendformen. Theapprovedtestsavailableinthemarket areforscreeningwomenforcervicalcancers. Theyarenot usefulforthescreeningof HPV-relatedcancersorgenitalwartsinmen.
This report aims to provide a comprehensive presentation of the global market for Human Papillomavirus (HPV) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papillomavirus (HPV) Testing. This report contains market size and forecasts of Human Papillomavirus (HPV) Testing in global, including the following market information:
Global Human Papillomavirus (HPV) Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Human Papillomavirus (HPV) Testing market was valued at US$ 778.9 million in 2022 and is projected to reach US$ 1110.5 million by 2029, at a CAGR of 5.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pap Smear Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Papillomavirus (HPV) Testing include Roche, Agilent Technologies, Becton, DickinsonandCompany, QiagenN.V., Thermo FisherScientificInc., Abbott Laboratories, HologicInc., CepheidInc. and SeegeneInc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Papillomavirus (HPV) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Papillomavirus (HPV) Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Papillomavirus (HPV) Testing Market Segment Percentages, by Type, 2022 (%)
Pap Smear Test
HPV DNA Test
Global Human Papillomavirus (HPV) Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Papillomavirus (HPV) Testing Market Segment Percentages, by Application, 2022 (%)
Diagnostic Centers
Hospitals
Clinic
Global Human Papillomavirus (HPV) Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Papillomavirus (HPV) Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Papillomavirus (HPV) Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Papillomavirus (HPV) Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Papillomavirus (HPV) Testing, market overview.
Chapter 2: Global Human Papillomavirus (HPV) Testing market size in revenue.
Chapter 3: Detailed analysis of Human Papillomavirus (HPV) Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Papillomavirus (HPV) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Human Papillomavirus (HPV) Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Human Papillomavirus (HPV) Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Human Papillomavirus (HPV) Testing Overall Market Size
    2.1 Global Human Papillomavirus (HPV) Testing Market Size: 2022 VS 2029
    2.2 Global Human Papillomavirus (HPV) Testing Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Human Papillomavirus (HPV) Testing Players in Global Market
    3.2 Top Global Human Papillomavirus (HPV) Testing Companies Ranked by Revenue
    3.3 Global Human Papillomavirus (HPV) Testing Revenue by Companies
    3.4 Top 3 and Top 5 Human Papillomavirus (HPV) Testing Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Human Papillomavirus (HPV) Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Human Papillomavirus (HPV) Testing Players in Global Market
        3.6.1 List of Global Tier 1 Human Papillomavirus (HPV) Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Human Papillomavirus (HPV) Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Human Papillomavirus (HPV) Testing Market Size Markets, 2022 & 2029
        4.1.2 Pap Smear Test
        4.1.3 HPV DNA Test
    4.2 By Type - Global Human Papillomavirus (HPV) Testing Revenue & Forecasts
        4.2.1 By Type - Global Human Papillomavirus (HPV) Testing Revenue, 2018-2023
        4.2.2 By Type - Global Human Papillomavirus (HPV) Testing Revenue, 2024-2029
        4.2.3 By Type - Global Human Papillomavirus (HPV) Testing Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Human Papillomavirus (HPV) Testing Market Size, 2022 & 2029
        5.1.2 Diagnostic Centers
        5.1.3 Hospitals
        5.1.4 Clinic
    5.2 By Application - Global Human Papillomavirus (HPV) Testing Revenue & Forecasts
        5.2.1 By Application - Global Human Papillomavirus (HPV) Testing Revenue, 2018-2023
        5.2.2 By Application - Global Human Papillomavirus (HPV) Testing Revenue, 2024-2029
        5.2.3 By Application - Global Human Papillomavirus (HPV) Testing Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Human Papillomavirus (HPV) Testing Market Size, 2022 & 2029
    6.2 By Region - Global Human Papillomavirus (HPV) Testing Revenue & Forecasts
        6.2.1 By Region - Global Human Papillomavirus (HPV) Testing Revenue, 2018-2023
        6.2.2 By Region - Global Human Papillomavirus (HPV) Testing Revenue, 2024-2029
        6.2.3 By Region - Global Human Papillomavirus (HPV) Testing Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Human Papillomavirus (HPV) Testing Revenue, 2018-2029
        6.3.2 US Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.3.3 Canada Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.3.4 Mexico Human Papillomavirus (HPV) Testing Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Human Papillomavirus (HPV) Testing Revenue, 2018-2029
        6.4.2 Germany Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.4.3 France Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.4.4 U.K. Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.4.5 Italy Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.4.6 Russia Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.4.7 Nordic Countries Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.4.8 Benelux Human Papillomavirus (HPV) Testing Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Human Papillomavirus (HPV) Testing Revenue, 2018-2029
        6.5.2 China Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.5.3 Japan Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.5.4 South Korea Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.5.5 Southeast Asia Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.5.6 India Human Papillomavirus (HPV) Testing Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Human Papillomavirus (HPV) Testing Revenue, 2018-2029
        6.6.2 Brazil Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.6.3 Argentina Human Papillomavirus (HPV) Testing Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Human Papillomavirus (HPV) Testing Revenue, 2018-2029
        6.7.2 Turkey Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.7.3 Israel Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.7.4 Saudi Arabia Human Papillomavirus (HPV) Testing Market Size, 2018-2029
        6.7.5 UAE Human Papillomavirus (HPV) Testing Market Size, 2018-2029
7 Human Papillomavirus (HPV) Testing Companies Profiles
    7.1 Roche
        7.1.1 Roche Company Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Human Papillomavirus (HPV) Testing Major Product Offerings
        7.1.4 Roche Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.1.5 Roche Key News & Latest Developments
    7.2 Agilent Technologies
        7.2.1 Agilent Technologies Company Summary
        7.2.2 Agilent Technologies Business Overview
        7.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Major Product Offerings
        7.2.4 Agilent Technologies Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.2.5 Agilent Technologies Key News & Latest Developments
    7.3 Becton, DickinsonandCompany
        7.3.1 Becton, DickinsonandCompany Company Summary
        7.3.2 Becton, DickinsonandCompany Business Overview
        7.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Major Product Offerings
        7.3.4 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.3.5 Becton, DickinsonandCompany Key News & Latest Developments
    7.4 QiagenN.V.
        7.4.1 QiagenN.V. Company Summary
        7.4.2 QiagenN.V. Business Overview
        7.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.4.4 QiagenN.V. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.4.5 QiagenN.V. Key News & Latest Developments
    7.5 Thermo FisherScientificInc.
        7.5.1 Thermo FisherScientificInc. Company Summary
        7.5.2 Thermo FisherScientificInc. Business Overview
        7.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.5.4 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.5.5 Thermo FisherScientificInc. Key News & Latest Developments
    7.6 Abbott Laboratories
        7.6.1 Abbott Laboratories Company Summary
        7.6.2 Abbott Laboratories Business Overview
        7.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Major Product Offerings
        7.6.4 Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.6.5 Abbott Laboratories Key News & Latest Developments
    7.7 HologicInc.
        7.7.1 HologicInc. Company Summary
        7.7.2 HologicInc. Business Overview
        7.7.3 HologicInc. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.7.4 HologicInc. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.7.5 HologicInc. Key News & Latest Developments
    7.8 CepheidInc.
        7.8.1 CepheidInc. Company Summary
        7.8.2 CepheidInc. Business Overview
        7.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.8.4 CepheidInc. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.8.5 CepheidInc. Key News & Latest Developments
    7.9 SeegeneInc.
        7.9.1 SeegeneInc. Company Summary
        7.9.2 SeegeneInc. Business Overview
        7.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.9.4 SeegeneInc. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.9.5 SeegeneInc. Key News & Latest Developments
    7.10 TakaraBio Inc.
        7.10.1 TakaraBio Inc. Company Summary
        7.10.2 TakaraBio Inc. Business Overview
        7.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.10.4 TakaraBio Inc. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.10.5 TakaraBio Inc. Key News & Latest Developments
    7.11 DaAnGeneof SunYat-SenUniversity
        7.11.1 DaAnGeneof SunYat-SenUniversity Company Summary
        7.11.2 DaAnGeneof SunYat-SenUniversity Business Overview
        7.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Major Product Offerings
        7.11.4 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.11.5 DaAnGeneof SunYat-SenUniversity Key News & Latest Developments
    7.12 PromegaCorporation
        7.12.1 PromegaCorporation Company Summary
        7.12.2 PromegaCorporation Business Overview
        7.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Major Product Offerings
        7.12.4 PromegaCorporation Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.12.5 PromegaCorporation Key News & Latest Developments
    7.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
        7.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Summary
        7.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
        7.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Major Product Offerings
        7.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Key News & Latest Developments
    7.14 Enzo Biochem Inc.
        7.14.1 Enzo Biochem Inc. Company Summary
        7.14.2 Enzo Biochem Inc. Business Overview
        7.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Major Product Offerings
        7.14.4 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.14.5 Enzo Biochem Inc. Key News & Latest Developments
    7.15 NorgenBiotek
        7.15.1 NorgenBiotek Company Summary
        7.15.2 NorgenBiotek Business Overview
        7.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Major Product Offerings
        7.15.4 NorgenBiotek Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.15.5 NorgenBiotek Key News & Latest Developments
    7.16 DiagCorBioscienceIncLtd
        7.16.1 DiagCorBioscienceIncLtd Company Summary
        7.16.2 DiagCorBioscienceIncLtd Business Overview
        7.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Major Product Offerings
        7.16.4 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.16.5 DiagCorBioscienceIncLtd Key News & Latest Developments
    7.17 Hybribio Limited
        7.17.1 Hybribio Limited Company Summary
        7.17.2 Hybribio Limited Business Overview
        7.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Major Product Offerings
        7.17.4 Hybribio Limited Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.17.5 Hybribio Limited Key News & Latest Developments
    7.18 ZytovisionGmbH
        7.18.1 ZytovisionGmbH Company Summary
        7.18.2 ZytovisionGmbH Business Overview
        7.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Major Product Offerings
        7.18.4 ZytovisionGmbH Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.18.5 ZytovisionGmbH Key News & Latest Developments
    7.19 ArborVitaCorporation
        7.19.1 ArborVitaCorporation Company Summary
        7.19.2 ArborVitaCorporation Business Overview
        7.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Major Product Offerings
        7.19.4 ArborVitaCorporation Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.19.5 ArborVitaCorporation Key News & Latest Developments
    7.20 Medical& BiologicalLaboratoriesCo., Ltd
        7.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Summary
        7.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview
        7.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Major Product Offerings
        7.20.4 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.20.5 Medical& BiologicalLaboratoriesCo., Ltd Key News & Latest Developments
    7.21 Fujirebio Diagnostics
        7.21.1 Fujirebio Diagnostics Company Summary
        7.21.2 Fujirebio Diagnostics Business Overview
        7.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Major Product Offerings
        7.21.4 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue in Global Market (2018-2023)
        7.21.5 Fujirebio Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Human Papillomavirus (HPV) Testing Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?